Politics

Exclusive Lizzy Lawrence

STAT Plus: Jeff Shuren, medical devices head at FDA, to leave the agency

Politics John Wilkerson

STAT Plus: House hearing keeps pressure on PBM practices while Congress considers reforms

Politics Nicholas Florko

STAT Plus: Medical groups are divided over Biden plan to loosen DEA restrictions on marijuana

Politics Sarah Owermohle and Rachel Cohrs Zhang

STAT Plus: Harris health care agenda swiftly hailed by progressives and reproductive rights groups

Politics Rachel Cohrs Zhang and Sarah Owermohle

STAT Plus: Kamala Harris, endorsed by Biden to replace him, is left of the president on health care

Politics John Wilkerson and Rachel Cohrs Zhang

STAT Plus: Where 3 Democrats who could replace Biden atop the ticket stand on health care

Politics Sarah Owermohle

STAT Plus: Trump campaign provides new details on his ear wound and treatment

Politics Sarah Owermohle

STAT Plus: Trump rallies his base on bolstering health care, avoiding thorny questions about health rights

Politics Olivia Goldhill

STAT Plus: FDA investigators have not spoken with patients and others alleging misconduct in MDMA trials

Politics Nicholas Florko

STAT Plus: ‘Legal’ psychedelic mushrooms actually contain illegal hallucinogens, study shows

Politics Lev Facher and Sarah Owermohle

STAT Plus: JD Vance’s rhetoric, and record, on the opioid epidemic

Politics Rachel Cohrs Zhang and John Wilkerson

STAT Plus: Q&A: The new CEO of biotech’s top trade group on China, vaccines, and Trump

Politics Usha Lee McFarling and Rohan Rajeev

STAT Plus: Physicians weigh in on potential impact of Trump’s ear wound: ‘It’s a matter of inches’

Politics Annalisa Merelli

STAT Plus: Sen. Menendez’s conviction may cost pharma a key ally in Congress

The Readout Elaine Chen

STAT Plus: Roche looks to have a competitive GLP-1 drug

Politics Rachel Cohrs Zhang and Sarah Owermohle

STAT Plus: What to know about Trump VP pick J.D. Vance’s health care views and investments

The Readout Meghana Keshavan

STAT Plus: What are the odds we get an heir to Paxlovid?

Politics John Wilkerson

STAT Plus: The effort to reform physician pay is set to pit primary care docs against highly paid specialists

Exclusive Nicholas Florko

STAT Plus: Top FDA officials weighing regulation of ultra-processed foods, internal documents show

The Readout Meghana Keshavan

STAT Plus: Element Biosciences raises another massive round

The Readout Elaine Chen

STAT Plus: Can you get satiety with GLP-1s without the nausea?

Health Sarah Owermohle

STAT Plus: Elmo and his friends are helping little kids (and grown-ups) with their ‘big feelings’ amid a mental health crisis

Politics Bob Herman

STAT Plus: Biden administration ignores calls to bolster hospital price transparency

The Readout Elaine Chen

STAT Plus: uniQure shares soar on Huntington’s data

D.C. Diagnosis Sarah Owermohle

STAT Plus: The pharmaceutical industry keeps losing Washington friends

The Readout Elaine Chen

STAT Plus: Lilly’s obesity drug looks more potent than Novo’s in observational study

Politics Rachel Cohrs Zhang

STAT Plus: Drugmakers are losing crucial friends on Capitol Hill

Politics Sarah Owermohle and Rachel Cohrs Zhang

STAT Plus: Trump’s 2024 platform abandons calls to cut Medicare, broadly restrict abortion

The Readout Meghana Keshavan

STAT Plus: The biotech news you missed this week